Venmax Drugs And Pharmaceuticals Ltd Q4 FY25 Results
VENMAXQ4 FY25 ResultsAnnounced 9 May 2025, 01:31 pm| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 0.33 | 67.2% |
| Total Income | 1.36 | 581.4% |
| Expenditure | 0.58 | 16.4% |
| PBT | 0.77 | 256.6% |
| Net Profit | 0.78 | 257.2% |
| OPM | -74.13% | |
| NPM | 57.39% | |
| EPS | 1.49 | 256.8% |
Informational and educational content only. Not investment advice.